Literature DB >> 8353040

Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.

M S Wilson1, C M West, G D Wilson, S A Roberts, R D James, P F Schofield.   

Abstract

Intra-tumoural heterogeneity of proliferation has been assessed by taking multiple biopsies from 30 colorectal cancers. Following in vivo IUDR labelling, dual parameter flow cytometry was used to measure tumour DNA index (DI) and labelling index (LI) and to derive DNA synthesis time (Ts) and potential doubling time (Tpot). Heterogeneity was seen for all parameters under investigation. Overall coefficients of variation (CV) and logarithmic transformation of Ts and Tpot (due to their non-gaussian distributions) indicate that LI (CV 25%) was the most variable parameter. Intra-tumoral heterogeneity in Tpot (lnTpot CV = 22%) was less than inter-individual variation (CV = 63%), suggesting that this variation should not be a limitation to the possible usefulness of this technique as an independent prognostic indicator. Correlations of Tpot values were examined between the shortest, the median and the value for a pooled homogenate sample from a single tumour. Using an homogenate, it was possible to accurately predict classification of tumour Tpot values as being below the median ('fast tumours') in 15 of 19 cases (79%). The data suggest that assaying an homogenate may allow a more rapid analysis of a multiply sampled tumour.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353040      PMCID: PMC1968401          DOI: 10.1038/bjc.1993.376

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  Heterogeneity of DNA distribution pattern in colorectal carcinoma. A microspectrophotometric study of fine needle aspirates.

Authors:  M Koha; T O Caspersson; B Wikström; B Brismar
Journal:  Anal Quant Cytol Histol       Date:  1990-10       Impact factor: 0.302

2.  Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours.

Authors:  D A Rew; I D Campbell; I Taylor; G D Wilson
Journal:  Br J Surg       Date:  1992-04       Impact factor: 6.939

3.  Lack of association between in vitro clonogenic growth of human cervical carcinoma and tumour stage, differentiation, patient age, host cell infiltration or patient survival.

Authors:  S E Davidson; C M West; R D Hunter
Journal:  Int J Cancer       Date:  1992-01-02       Impact factor: 7.396

4.  Assessment of human tumour proliferation using bromodeoxyuridine--current status.

Authors:  G D Wilson
Journal:  Acta Oncol       Date:  1991       Impact factor: 4.089

Review 5.  Adjuvant therapy for colorectal carcinoma.

Authors:  U Metzger
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

6.  Variability in DNA measurements in multiple tumor samples of human colonic carcinoma.

Authors:  R P Wersto; R L Liblit; D Deitch; L G Koss
Journal:  Cancer       Date:  1991-01-01       Impact factor: 6.860

7.  Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas.

Authors:  G Lindmark; B Glimelius; L Påhlman; P Enblad
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

8.  Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non-lymphoblastic leukaemia.

Authors:  A Riccardi; M Giordano; M Danova; M Girino; S Brugnatelli; G Ucci; G Mazzini
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

9.  Proliferation characteristics of human colorectal carcinomas measured in vivo.

Authors:  D A Rew; G D Wilson; I Taylor; P C Weaver
Journal:  Br J Surg       Date:  1991-01       Impact factor: 6.939

10.  Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.

Authors:  M H Bennett; G D Wilson; S Dische; M I Saunders; C A Martindale; B M Robinson; A E O'Halloran; M D Leslie; J H Laing
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

View more
  8 in total

Review 1.  Preoperative staging of gastric cancer as precondition for multimodal treatment.

Authors:  A Sendler; H J Dittler; H Feussner; H Nekarda; E Bollschweiler; U Fink; H Helmberger; H Höfler; J R Siewert
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

2.  Effect of glucagon on protein synthesis in human rectal cancer in situ.

Authors:  W H Hartl; H Demmelmair; K W Jauch; B Koletzko; F W Schildberg
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

3.  Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.

Authors:  R Palmqvist; A Oberg; C Bergström; J N Rutegård; B Zackrisson; R Stenling
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

4.  Labelling indices in human tumours: to apply corrections or not--that is the question.

Authors:  C Bergström; A Begg; R Palmqvist; A Waites; J Denekamp
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

5.  Cellular kinetics in rectal cancer.

Authors:  N H Terry; M L Meistrich; L D Roubein; P M Lynch; R A Dubrow; T A Rich
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

6.  Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045.

Authors:  G D Wilson; N Paschoud; J J Pavy; K Weber; P Weber; B Dubray; P A Coucke
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

7.  Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.

Authors:  Lik Hang Lee; Hua Yang; Gilbert Bigras
Journal:  Sci Rep       Date:  2014-05-30       Impact factor: 4.379

8.  Cancer recurrence times from a branching process model.

Authors:  Stefano Avanzini; Tibor Antal
Journal:  PLoS Comput Biol       Date:  2019-11-21       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.